Sanjay K Shivappa Selected Research

Sanjay K Shivappa Research Topics

2	Cerebral Palsy (Spastic Diplegia) 06/2021 - 10/2018
1	Sandhoff Disease (Sandhoff's Disease) 03/2022
1	Tay-Sachs Disease 03/2022
1	GM2 Gangliosidoses (GM2 Gangliosidosis) 03/2022
1	GM1 Gangliosidosis (Gangliosidosis GM1) 03/2022
1	Protein Deficiency 03/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2022
1	Gangliosidoses (Gangliosidosis) 03/2022
1	Diphtheria 01/2022
1	Paralysis (Palsy) 01/2022
1	Ataxia (Dyssynergia) 09/2021
1	Globoid Cell Leukodystrophy (Krabbe Disease) 09/2021
1	Leukoencephalopathies 09/2021
1	Aromatic amino acid decarboxylase deficiency 06/2021
1	Hereditary Folate Malabsorption 01/2021
1	Leukopenia 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Bradycardia 07/2020
1	Status Epilepticus (Complex Partial Status Epilepticus) 07/2020
1	Seizures (Absence Seizure) 07/2020
1	Spasm (Spasms) 02/2019
1	Infantile Spasms (West Syndrome) 02/2019

2	EnzymesIBA 03/2022 - 09/2021
1	G(M2) Ganglioside (Ganglioside GM2)IBA 03/2022
1	GlycosphingolipidsIBA 03/2022
1	ExotoxinsIBA 01/2022
1	Eukaryotic Initiation Factor-2B (Eukaryotic Initiation Factor 2B)IBA 09/2021
1	Peptide Initiation Factors (Initiation Factor)IBA 09/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 06/2021
1	Proton-Coupled Folate TransporterIBA 01/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021
1	Levetiracetam (Keppra)FDA LinkGeneric 07/2020
1	Pharmaceutical PreparationsIBA 07/2020
1	fosphenytoin (Cerebyx)FDA LinkGeneric 07/2020
1	Lorazepam (Ativan)FDA LinkGeneric 07/2020
1	Prednisolone (Predate)FDA LinkGeneric 02/2019
1	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2019
1	Type A Botulinum Toxins (Botox)FDA Link 10/2018

1	Therapeutics 02/2019